Protara Therapeutics, Inc. (TARA) Social Stream
PROTARA THERAPEUTICS INC (TARA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering TARA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 3 | $50 | $34 | $40.5 | $2.14 | 1792.52% |
| 2022-03-10 | 4 | $50 | $34 | $40.5 | $2.14 | 1792.52% |
| 2022-03-14 | 4 | $40 | $32 | $36.666 | $2.14 | 1613.36% |
| 2022-05-06 | 4 | $40 | $32 | $34.666 | $2.14 | 1519.91% |
| 2022-05-09 | 4 | $32 | $30 | $31.333 | $2.14 | 1364.16% |
| 2022-05-11 | 4 | $32 | $26 | $29.333 | $2.14 | 1270.7% |
| 2022-08-11 | 4 | $32 | $23 | $28.333 | $2.14 | 1223.97% |
| 2022-11-07 | 3 | $50 | $23 | $33.75 | $2.14 | 1477.1% |
| 2023-05-03 | 4 | $50.001 | $23 | $33.75 | $2.14 | 1477.1% |
| 2023-05-08 | 4 | $50 | $23 | $33.75 | $2.14 | 1477.1% |
| 2023-11-06 | 5 | $50 | $22 | $31.4 | $2.14 | 1367.29% |
The Trend in the Analyst Price Target
Over the past 35 weeks, TARA's average price target has gone down $3.15.
TARA reports an average of 1,297.86% for its upside potential over the past 35 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-24 | 4 | 50.001 | 23 | 33.75 | 3.59 | 840.11% |
| 2023-05-03 | 4 | 50.001 | 23 | 33.75 | 3.09 | 992.23% |
| 2023-05-08 | 5 | 50.000 | 23 | 33.75 | 3.09 | 992.23% |
| 2023-08-03 | 5 | 50.000 | 22 | 31.40 | 2.54 | 1136.22% |
| 2023-08-04 | 5 | 50.000 | 22 | 31.40 | 2.42 | 1197.52% |
TARA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
TARA's average broker recommendation rating improved by 0.25 over the prior 29 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TARA as an investment opportunity.
- PROTARA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 1472.12% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the micro market cap category, PROTARA THERAPEUTICS INC's average analyst price target is higher than 1390.81% of them.
- In the context of Healthcare stocks, PROTARA THERAPEUTICS INC's number of analysts covering the stock is higher than 255.36% of them.
- In terms of how PROTARA THERAPEUTICS INC fares relative to Healthcare stocks, note that its variance in analysts' estimates is lower than -513.1% of that group.
Stocks similar to PROTARA THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are TCON, FENC, and IKT.
View All Top Stocks by Price Target
What is the outlook for TARA? Use POWR Ratings for clearer insight into price direction.